XORTX Therapeutics Inc.
XRTX
$0.88
$0.011.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -445.09% | 105.63% | -211.84% | 302.43% | 21.19% |
| Total Depreciation and Amortization | -21.52% | 2.80% | 31.56% | 47.88% | -48.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 84.52% | -179.55% | 155.68% | -15,139.17% | -8.40% |
| Change in Net Operating Assets | -91.40% | 301.65% | 20.69% | -285.51% | 332.67% |
| Cash from Operations | -2.09% | 43.52% | -0.45% | -21.24% | 38.08% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -154.95% | -250.00% | 73.47% | -34.25% | 7.59% |
| Cash from Investing | -154.95% | -250.00% | 73.47% | -34.25% | 23.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -149.44% | 44.03% | 6.47% | -1.80% | -1.83% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -0.78% | -- | -- |
| Cash from Financing | -149.44% | -100.52% | 645.50% | -1,770.06% | -65.35% |
| Foreign Exchange rate Adjustments | 880.00% | 73.12% | -520.00% | -650.00% | -104.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.73% | -295.20% | 123.91% | -48.10% | 37.23% |
